Skip to content
Clinical Trials – home

Diamond Clinic Sp. z o.o.

Verified siteinfoFast reply

Poland Ul. Stefana Rogozinskiego 6/U3, 31-559 Cracow, Poland

  • 9 trials recruiting
  • Dermatitis atopic · Asthma · Chronic obstructive pulmonary disease
  • Adults and children

About Specializations

Diamond Clinic Sp. z o.o. in Cracow, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Asthma, Chronic obstructive pulmonary disease, Neurodermatitis, and other specialisations. This site conducts important research.

Main research areas of the site

Respiratory Disease Research

At Diamond Medical Center in Cracow, clinical research in respiratory tract diseases focuses on asthma and the broader study of immune system processes involved in long-term disease control. The trials are designed to assess whether new treatments can improve safety, tolerability, and overall symptom management for people living with chronic airway disease.

  • Evaluating the safety and tolerability of a new therapy for adult asthma
  • Studying treatment effectiveness in people with moderate to severe respiratory disease
  • Supporting better long-term management of chronic airway inflammation

This work reflects a strong interest in immune system diseases linked to breathing disorders, with a practical focus on improving outcomes for patients who need sustained treatment.

Dermatology and Immune-Mediated Skin Disease

Clinical trials at Diamond Clinic Sp. z o.o. also explore skin and connective tissue diseases, especially atopic dermatitis. These studies aim to determine whether new therapies can reduce symptoms, improve skin clearance, and offer better options for people with moderate to severe disease.

  • Testing a potential new treatment for moderate to severe atopic dermatitis
  • Measuring improvements in skin symptoms and disease control
  • Assessing the value of treatment options for patients who have not used similar therapies before

The dermatology program highlights the site’s interest in immune-related skin inflammation and in finding more effective approaches for chronic, relapsing conditions.

Hair Loss and Dermatologic Innovation

Research in androgenetic alopecia adds another dermatology-focused area to the site’s portfolio. These trials are intended to evaluate whether emerging treatments can help slow hair loss and support visible hair regrowth in adult men affected by male pattern baldness.

  • Assessing a treatment approach for male pattern hair loss
  • Examining both efficacy and safety in adult participants
  • Exploring new options for a common chronic skin-related condition

This line of research broadens the clinic’s work in skin and connective tissue diseases, with a clear emphasis on improving everyday quality of life through better cosmetic and clinical outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Stefana Rogozinskiego 6/U331-559 CracowPoland
Recruiting now
9 trials
Conditions studied
18
Partner status
Verified site

More sites in CracowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

44 clinical trials

Study of Brenipatide (LY3537031) in Adults with Major Depressive Disorder to Evaluate Delay of Relapse Compared with Placebo

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

Vitiligo

Recruiting

Efficacy and Safety of LY4005130 Compared with Placebo in Adults with Non‑Segmental Vitiligo

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Asthma

Recruiting

A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Vitiligo

Recruiting

Study of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ruxolitinib
  • Sponsor:Incyte Corp.

Vitiligo+2

Recruiting

Long-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

A study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:UCB Biopharma

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Beclometasone Dipropionate
  • Sponsor:Chiesi Farmaceutici S.p.A.

Dermatitis atopic

Not yet recruiting

Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Novartis Pharma AG

Dermatitis atopic

Not yet recruiting

Study on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:ANB032
  • Sponsor:Anaptysbio Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.